Related by context. Frequent words. (Click for all words.) 64 CYPHER ® Stent 62 placebo controlled clinical 60 COPAXONE R 59 RTOG 58 CYPHER R Stent 58 randomized controlled clinical 58 Endeavor stent 58 randomized controlled clinical trials 58 randomized Phase III 58 TAXUS 57 phase IIa 57 placebo controlled studies 57 axitinib 57 SPIRIT III 56 tesmilifene 56 substudy 56 prospective randomized controlled 56 Phase 2a trial 56 randomized clinical trials 56 bronchial thermoplasty 56 multicentre 56 TAXUS stent 56 Phase 1a 56 multicenter clinical 56 HER2 positive metastatic breast 56 Phase 1b 56 retrospective cohort study 56 carotid stenting 55 ADHF 55 Phase 1b trial 55 muraglitazar 55 randomized clinical 55 meta analyzes 55 placebo controlled trials 55 secondary efficacy endpoints 55 prospective observational 55 Phase 2b 55 Phase 2b study 55 multicenter study 54 azacitidine 54 Phase Ib 54 CAPRISA 54 Mylotarg 54 MitraClip 54 randomized trials 54 subgroup analyzes 54 imetelstat 54 phase IIb 54 noninferiority 54 active comparator 54 multicenter 54 Phase 2a clinical 54 darapladib 54 elagolix 54 Neuradiab 54 PROPEL trial 53 Coronary Stent 53 dose cohorts 53 dose escalation 53 pazopanib 53 EORTC 53 TORISEL 53 fondaparinux 53 placebo controlled 53 sustained virologic response 53 tocilizumab 53 peginterferon 53 neoadjuvant 53 Phase 2b clinical 53 acute ischemic stroke 53 sunitinib 53 phase 2a 53 pharmacodynamic 53 virologic response 53 composite endpoint 53 neoadjuvant chemotherapy 52 antithrombotic 52 ACC AHA 52 randomized controlled 52 NIH Roadmap 52 stable angina 52 Phase III 52 CATIE 52 End Results SEER 52 prespecified 52 ACTEMRA 52 alvimopan 52 coronary revascularization 52 lipid lowering drugs 52 nab paclitaxel 52 tiotropium 52 clinical trial 52 NHANES 52 Phase Ia 52 placebo controlled randomized 52 candesartan 52 MDV# 52 blind randomized controlled 52 Secondary endpoints 51 meta analysis 51 risk stratification